2-methylpentane has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamisuki, S; Kuramochi, K; Murakami, H; Nagane, M; Nakamura, A; Nakamura, K; Nishioka, K; Nishiuchi, K; Ohashi, H; Okada, M; Otagaki, J; Saito, S; Shibasaki, H; Tsurukawa, Y; Watashi, K | 1 |
| Sinha, P; Yadav, AK | 1 |
2 other study(ies) available for 2-methylpentane and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Cyclic Phthalate Esters as Liver X Receptor Antagonists with Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties.
Topics: Antiviral Agents; COVID-19; Esters; Hepacivirus; Hexanes; Humans; Liver X Receptors; Phthalic Acids; Receptors, Cytoplasmic and Nuclear; SARS-CoV-2; Solvents | 2022 |
In silico identification and molecular dynamic simulations of derivatives of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide against main protease 3CL
Topics: Antiviral Agents; COVID-19; Hexanes; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Peptide Hydrolases; Protease Inhibitors; SARS-CoV-2 | 2023 |